MEDICATION USE AMONG T2DM PATIENTS INITIATING TREATMENT WITH ONCE WEEKLY (OW) SEMAGLUTIDE

被引:0
|
作者
Frazer, M. [1 ]
Swift, C. [2 ]
Sargent, A. [3 ]
Leszko, M. [3 ]
Buysman, E. K. [3 ]
Alvarez, S. [4 ]
Noone, J. [2 ]
Gamble, C. [2 ]
机构
[1] Qual Metr, Johnston, RI USA
[2] Novo Nordisk Inc, Plainsboro, NJ USA
[3] Optum, Eden Prairie, MN USA
[4] Novo Nordisk Inc, Tacoma, WA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HSD49
引用
收藏
页码:S246 / S246
页数:1
相关论文
共 50 条
  • [41] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [42] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
  • [43] Phase 1 Study of Safety, Tolerability, PK, and PD of Once-Weekly Basal Insulin Fc (BIF) in Japanese Patients with T2DM
    Ohwaki, Kenji
    Furihata, Kenichi
    Nasu, Risa
    Oura, Tomonori
    Imori, Makoto
    DIABETES, 2021, 70
  • [44] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Xueyu Yan
    Jinglei Si
    Fangjie Zhong
    Yanjun Wu
    Qinyang Jiang
    Yafen Guo
    Xiurong Yang
    Jing Liang
    Ganqiu Lan
    International Journal of Diabetes in Developing Countries, 2022, 42 : 236 - 244
  • [45] ACHIEVING TARGET GOALS IN PATIENTS WITH T2DM TREATED WITH EXENATIDE ONCE WEEKLY OR INSULIN GLARGINE: A RETROSPECTIVE ANALYSIS OF THE NUMBER-NEEDED-TO-TREAT
    Bruhn, D.
    Han, J.
    Meloni, A.
    DeYoung, M. B.
    Anderson, P. W.
    VALUE IN HEALTH, 2011, 14 (07) : A473 - A473
  • [46] Evaluation of global longitudinal strain and EAT in patients with T2DM treated with oral semaglutide: a pilot study
    Braha, A.
    Timar, B.
    Ivan, V.
    Balica, M. Miclos
    Daniluc, L.
    Timar, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [47] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    PLOS ONE, 2022, 17 (08):
  • [48] COST-EFFECTIVENESS ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN MEXICO
    Valdez-Huerta, R.
    Moreno, D.
    Hernandez, Paladio J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S429 - S429
  • [49] Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials
    Jendle, Johan
    Birkenfeld, Andreas L.
    Polonsky, William H.
    Silver, Robert
    Uusinarkaus, Kari
    Hansen, Thomas
    Hakan-Bloch, Jonas
    Tadayon, Sayeh
    Davies, Melanie J.
    DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2315 - 2326
  • [50] Association between Hypoglycemia and Medication Adherence among Veterans With Type 2 Diabetes Mellitus (T2DM)
    Zhao, Yingnan
    Campbell, Claudia
    Fonseca, Vivian
    Shi, Lizheng
    DIABETES, 2012, 61 : A553 - A553